Human Papillomavirus (HPV) Testing Market is expected to reach nearly US$ 1 Bn by the end of 2025 at a CAGR of 7.6%

The Human Papillomavirus (HPV) Testing Market is a sector of the healthcare industry that focuses on the diagnosis and management of HPV infections. HPV is a sexually transmitted virus that can cause genital warts and certain types of cancer, including cervical, anal, and oropharyngeal cancer.

There are several methods for detecting HPV infections, including DNA testing, Pap smears, and visual inspection with acetic acid (VIA). DNA testing is the most accurate method for detecting HPV, but it is also the most expensive. Pap smears, which involve collecting cells from the cervix and examining them under a microscope, are a less accurate but more affordable option. VIA involves applying a diluted vinegar solution to the cervix and looking for changes in the appearance of the tissue that may indicate the presence of HPV.

Request For Free Sample Report of "Human Papillomavirus (HPV) Testing Market"@ https://www.persistencemarketresearch.com/samples/11737

In addition to traditional laboratory-based testing, there are also several HPV tests that can be performed at the point of care (POC), such as self-sampling kits, which allow individuals to collect their own samples at home, and visual inspection with acetic acid (VIA), which is a low-cost method for identifying abnormal cervical cells.

Companies

Hoffmann-La Roche Ltd.
Agilent Technologies, Inc.
Becton, Dickinson and Company
Qiagen N.V.
Thermo Fisher Scientific Inc.
Abbott Laboratories
Hologic Inc.
Cepheid Inc.
Seegene Inc.
Takara Bio Inc.
DaAn Gene Co., Ltd. of Sun Yat-Sen University
Promega Corporation

 Buy Full Report Now and Get Up to 20% Discount @ https://www.persistencemarketresearch.com/checkout/11737

The HPV testing market is driven by factors such as increasing prevalence of HPV-related diseases, growing awareness about the importance of HPV vaccination and screening, and advances in HPV testing technology. However, the market is also faced with challenges such as low awareness and understanding of HPV among the general population, limited access to testing and vaccination services in certain regions, and high costs associated with some HPV tests.

Overall, the HPV testing market is expected to experience strong growth in the coming years, with increasing demand for HPV tests and advances in testing technology leading to the development of more accurate and convenient tests for the detection of HPV.

HPV screening tests are limited to women and this acts as a growth restraint

HPV infections can infect the genital areas of men including the skin on and around the. These infections can also be spread to the mouth and the throat. According to CDC, about 1% of sexually active men in the U.S. have genital warts at any given time.

Even when HPV infections are persistent to the male population and can cause severe diseases such as genital warts, anal cancers, cancers, and cancers of the oropharynx, there is currently no HPV test recommend for men.

The approved tests available in the market are for screening women for cervical cancers. They are not useful for the screening of HPV-related cancers or genital warts in men. The selective product availability has restricted the growth of the market to a specific gender leading to slow growth over the forecast period.

Request Customization @ https://www.persistencemarketresearch.com/request-customization/11737

Market Taxonomy

Product
DNA-based Test
RNA-based Test

End User
Hospitals
Clinics
Diagnostic Centers
Research Institutes

Applications
Molecular Diagnostics
Research Use

Region
North America
Latin America
Europe
Asia Pacific
Middle East and Africa

 
For More Premium Insights, Check out the Link:

Psoriasis Drugs Market -https://www.prnewswire.com/news-releases/psoriasis-drugs-market-is-predicted-to-progress-at-a-cagr-of-6-5-to-reach-a-valuation-of-us-21-48-bn-by-2031--301482350.html

Botulinum Toxin Market - https://www.prnewswire.com/news-releases/botulinum-toxin-market-is-set-to-expand-at-a-cagr-of-6-9-and-reach-a-valuation-of-us-10-7-bn-by-2031--301477267.html

Wearable Injectors Market - https://www.prnewswire.com/news-releases/wearable-injectors-market-expanding-at-a-cagr-of-around-11-8-over-the-forecast-period-2021-2031---persistence-market-research-301477856.html

Media Contact:
Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1-646-568-7751
Call +1 800-961-0353
sales@persistencemarketresearch.com

About Us

Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.

This release was published on openPR.